Gita Suneja

Composition by Sex of State and Federal Legislative Health Committees

Daeun Sung, Michael K. Rooney, Latifat Sulaimon, Reshma Jagsi et autres

This cross-sectional study examines the composition of state and federal legislative health committees by sex.

us (code pays fourni par la source)

Abstract 7862: Population analysis and immunologic landscape of melanoma in people living with HIV.

Lindsay N. Barger, Derek Wang, Ashley L. Saravia, Valeria Mezzano et autres

Abstract Purpose: To dissect the clinical and immunological features of people living with HIV (PLWH) diagnosed with melanoma, who have consistently shown worse outcomes than HIV-negative individuals (PLw/oH) with the same cancer. Experimental Design: We analyzed electronic health records from 1,087 PLWH …

us (code pays fourni par la source)

Social support across the cancer care continuum in Malawi: Narratives from cancer survivors

Abhilasha Khatri, Melissa H. Watt, Nehal K. Bakshi, Gita Suneja et autres

Informational, emotional, and instrumental social support can help individuals cope with life stressors like a cancer diagnosis. As the cancer burden in lower-and middle-income countries continues to increase, patients with cancer face challenges that may be alleviated in part through the provision …

us (code pays fourni par la source)

Development and psychometric properties of a general cancer stigma scale

Stephen Kimani, Gita Suneja, Agatha Kapatuka Bula, Chaorong Wu et autres

Cancer stigma negatively impacts diagnosis, quality of life, and survival outcomes, yet stigma reduction efforts are hindered by the lack of a valid and universal scale to measure cancer stigma. This study aimed to develop and validate a global cancer stigma scale, …

us (code pays fourni par la source)

Potential drug-drug interactions between cancer therapies and active antiretroviral treatments among Medicare-enrolled patients with cancer and HIV

Jessica Y. Islam, Jennifer Leigh Lund, Gita Suneja, Christine Jamjian et autres

us (code pays fourni par la source)

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study

Matthew Hamby, Brian L. Egleston, Zachary AK Frosch, Ariela Noy et autres

us, nl (code pays fourni par la source)

Comparison of QuPath and HALO Platforms for Analysis of the Tumor Microenvironment in Prostate Cancer

Jonathan V. Nguyen, Érika Said Abu Egal, Qian Yang, Michael R. Freeman et autres

us (code pays fourni par la source)

Identification and Management of Late Toxicities After Radiation Therapy for Vulvar Cancer

Cristina M. DeCesaris, Sabrina Bedell, David K. Gaffney, Gita Suneja et autres

us (code pays fourni par la source)

Supplemental Table 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers

Jordan Bruce Fenlon, Nathan Van Bibber, Jonathon Mahlow, Kosj Yamoah et autres

Supplemental Table 1: Number of Study Specimens by HIV Status, Cancer Type, and Source.

Supplemental Figure 1 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers

Jordan Bruce Fenlon, Nathan Van Bibber, Jonathon Mahlow, Kosj Yamoah et autres

Supplemental Figure 1: Percentage of tumor cells staining positive for immune markers, and age and race-adjusted associations (ORs [95% CI]) between tumor immune marker staining abundance and patient HIV status, by cancer type. All immune markers associations are shown.

Data from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers

Jordan Bruce Fenlon, Nathan Van Bibber, Jonathon Mahlow, Kosj Yamoah et autres

AbstractBackground: Cancer outcomes in people living with human immunodeficiency virus (PWH) may be driven in part by a distinct tumor microenvironment (TME) for cancers that develop in the setting of persistent immune dysfunction. Methods: Tumor samples from PWH were retrospectively obtained from …

Supplemental Table 2 from Human Immunodeficiency Virus–Associated Differences in the Tumor Immune Microenvironment of Lung, Breast, and Prostate Cancers

Jordan Bruce Fenlon, Nathan Van Bibber, Jonathon Mahlow, Kosj Yamoah et autres

Supplemental Table 2: Number of Tumor Samples, and Number (%) Individual Patients, with Tissue Staining Results Available, by Immune Marker and Cancer Type.